Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 4:58 pm Sale |
2022-12-31 | 13G | Avalo Therapeutics, Inc. AVTX |
Nantahala Capital Management, LLC | 2,728 7.000% |
-228 (-7.73%) |
Filing History |
| 2023-02-14 4:22 pm Purchase |
2022-12-31 | 13G | Avalo Therapeutics, Inc. AVTX |
Point72 Asset Management, L.P. | 2,086 5.300% |
2,086 (New Position) |
Filing History |
| 2023-02-14 4:09 pm Purchase |
2023-02-14 | 13G | Avalo Therapeutics, Inc. AVTX |
Caissa Capital Management ltd. | 5,807 10.570% |
1,721 (+42.13%) |
Filing History |
| 2023-02-13 4:10 pm Purchase |
2023-02-03 | 13G | Avalo Therapeutics, Inc. AVTX |
Great Point Partners, LLC | 4,061 7.120% |
4,061 (New Position) |
Filing History |
| 2023-02-09 4:27 pm Purchase |
2023-02-07 | 13D | Avalo Therapeutics, Inc. AVTX |
Armistice Capital, LLC | 19,928 35.400% |
1,876 (+10.39%) |
Filing History |
| 2022-08-11 4:09 pm Sale |
2022-08-08 | 13D | Avalo Therapeutics, Inc. AVTX |
Armistice Capital, LLC | 18,052 44.400% |
-0 (-0.00%) |
Filing History |
| 2022-08-08 07:23 am Purchase |
2022-07-25 | 13G | Avalo Therapeutics, Inc. AVTX |
Caissa Capital Management ltd. | 4,086 10.430% |
1,968 (+92.90%) |
Filing History |
| 2022-05-17 3:45 pm Purchase |
2022-05-04 | 13G | Avalo Therapeutics, Inc. AVTX |
Caissa Capital Management ltd. | 2,118 5.410% |
2,118 (New Position) |
Filing History |
| 2022-03-15 5:16 pm Purchase |
2022-03-14 | 13D | Avalo Therapeutics, Inc. AVTX |
Armistice Capital, LLC | 18,052 44.500% |
408 (+2.31%) |
Filing History |
| 2022-02-14 4:29 pm Purchase |
2021-12-31 | 13G | Avalo Therapeutics, Inc. AVTX |
Point72 Asset Management, L.P. | 2,088 5.400% |
1 (+0.05%) |
Filing History |
| 2022-02-14 08:07 am Purchase |
2021-12-31 | 13G | Avalo Therapeutics, Inc. AVTX |
Nantahala Capital Management, LLC | 2,956 7.500% |
2,956 (New Position) |
Filing History |
| 2022-01-19 6:41 pm Purchase |
2022-01-18 | 13D | Avalo Therapeutics, Inc. AVTX |
Armistice Capital, LLC | 17,643 43.700% |
486 (+2.83%) |
Filing History |
| 2021-12-16 4:04 pm Unchanged |
2021-12-14 | 13D | Avalo Therapeutics, Inc. AVTX |
Armistice Capital, LLC | 17,157 42.500% |
0 (Unchanged) |
Filing History |
| 2021-11-08 4:05 pm Unchanged |
2021-11-04 | 13D | Avalo Therapeutics, Inc. AVTX |
Armistice Capital, LLC | 17,157 43.900% |
0 (Unchanged) |
Filing History |
| 2021-10-14 9:01 pm Purchase |
2021-10-14 | 13D | Avalo Therapeutics, Inc. AVTX |
Armistice Capital, LLC | 17,157 43.900% |
143 (+0.84%) |
Filing History |
| 2021-09-21 4:51 pm Purchase |
2021-09-17 | 13G | Avalo Therapeutics, Inc. AVTX |
Point72 Asset Management, L.P. | 2,087 5.400% |
2,087 (New Position) |
Filing History |
| 2021-09-17 3:04 pm Purchase |
2021-09-17 | 13D | Avalo Therapeutics, Inc. AVTX |
Armistice Capital, LLC | 17,014 43.900% |
17,014 (New Position) |
Filing History |
| 2021-02-16 06:23 am Purchase |
2020-12-31 | 13G | Cerecor Inc. CERC |
Nantahala Capital Management, LLC | 6,233,316 8.300% |
6,233,316 (New Position) |
Filing History |
| 2021-01-12 5:11 pm Purchase |
2021-01-08 | 13D | Cerecor Inc. CERC |
Armistice Capital, LLC | 43,332,442 44.400% |
2,720,000 (+6.70%) |
Filing History |
| 2020-07-31 4:21 pm Sale |
2020-07-24 | 13D | Cerecor Inc. CERC |
Armistice Capital, LLC | 40,612,442 47.700% |
-1,128,000 (-2.70%) |
Filing History |